Rivers of Evidence

Document Type: Perspective


Cochrane Schizophrenia Group, Institute of Mental Health, University of Nottingham, UK


There has been too much of a one-way flow drift down a river of evidence. Researchers from rich countries have produced the primary evidence which they proceed to summarise within reviews. These summaries have directed care worldwide. However, things are changing and the river of evidence can flow in the other direction. The care of women with eclampsia has been changed or refined throughout the world because of a large low and middle income country trial. The global care of people with heart disease has been greatly modified by studies originating in China. The care of people who are acutely aggressive because of psychosis has to be reconsidered in the light of the evidence coming from Brazil and India. Healthcare is an issue everywhere and evaluation of care is not the premise of any one culture—the evidence—river must run both ways


Main Subjects


1. Cochrane AL. Effectiveness and Efficiency: Random Reflections on Health Services. London: Royal Society of Medicine Press; 1999.

2. Rayleigh L. Report of the fifty-fourth meeting of the British Association for the Advancement of Science; held at Montreal in August and September 1884. London: John Murray; 1885. p. 3-23. doi: 10.5962/bhl.title.38241

3. Glass GV. Primary, Secondary, and Meta-Analysis of Research. Educ Res 1976; 5: 3–8.

4. The Cochrane Collaboration. Working together to provide the best evidence for health care [Internet]. [cited 2011 May 16]. Available from: http://www.cochrane.org/

5. Sartorius N, Shapiro R, Kimura M, Barrett K. WHO international pilot study of schizophrenia. Psychol Med 1972; 2: 422–5. doi: 10.1017/s0033291700045244

6. Moll C, Gessler U, Bartsch S, El-Sayeh HG, Fenton M, Adams CE. Gross Domestic Product (GDP) and productivity of schizophrenia trials: an ecological study. BMC Psychiatry 2003; 3: 18. doi: 10.1186/1471-244X-3-18

7. Nasser M, Tibi A, Savage-Smith E. Ibn Sina’s Canon of Medicine: 11th century rules for assessing the effects of drugs. J R Soc Med 2009; 102: 78–80. doi: 10.1258/jrsm.2008.08k040

8. Medical Research Council. Streptomycin treatment of tuberculous meningitis. Lancet 1948; 1: 582–96. doi: 10.1016/s0140-6736(48)92003-0

9. Davis JM. Overview: maintenance therapy in psychiatry: I. Schizophrenia. Am J Psychiatry 1975; 132: 1237–45.

10. Chalmers I. The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci 1993; 703: 156–63. doi: 10.1111/j.1749-6632.1993.tb26345.x

11. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248–54. doi: 10.1056/nejm199207233270406

12. Association for Evidence-Based Medicine. Damascus Course [Internet]. [cited 2013 Feb 10]. Available from: https://www.facebook.com/pages/Association-for-Evidence-Based-Medicine/157205847667347

13. WHO. mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings [Internet]. [cited 2011 Sep 15]. Available from: http://www.who.int/mental_health/evidence/mhGAP_intervention_guide/en/index.html

14. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009; 62: 464–75. doi: 10.1016/j.jclinepi.2008.12.011

15. Collaborative Eclampsia Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455–63. doi: 10.1016/s0140-6736(95)91034-4

16. Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1607–21.

17. Huf G, Coutinho ESF, Adams CE. Physical restraints versus seclusion room for management of people with acute aggression or agitation due to psychotic illness (TREC-SAVE): a randomized trial. Psychol Med 2012; 42: 2265–73. doi: 10.1017/S0033291712000372

18. TREC Collaborative Group. Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine. BMJ 2003; 327: 708–13. doi: 10.1136/bmj.327.7417.708

19. Alexander J, Tharyan P, Adams C, John T, Mol C, Philip J. Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry J Ment Sci 2004; 185: 63–9. doi: 10.1192/bjp.185.1.63

20. Raveendran NS, Tharyan P, Alexander J, Adams CE. Rapid tranquillisation in psychiatric emergency settings in India: pragmatic randomised controlled trial of intramuscular olanzapine versus intramuscular haloperidol plus promethazine. BMJ 2007; 335: 865. doi: 10.1136/bmj.39341.608519.be

21. Huf G, Coutinho ESF, Adams CE. Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine. BMJ 2007; 335: 869. doi: 10.1136/bmj.39339.448819.ae

22. NICE. Violence: The short-term management of disturbed/violent behaviour in in-patient psychiatric settings and emergency departments [Internet]. [cited 2010 Nov 23]. Available from: http://guidance.nice.org.uk/CG25/

23. Takriti Y, El-Sayeh HG, Adams CE. Internet-based search of randomised trials relevant to mental health originating in the Arab world. BMC Psychiatry 2005; 5: 30.